May 28, 2015 — At the American Association of Neurological Surgeons (AANS) annual meeting, May 2-6 in Washington, D.C., Elekta highlighted Leksell Gamma Knife Registry. The cloud-based solution enables clinicians to leverage the data generated by thousands of Gamma Knife radiosurgery treatments each year to advance clinical research and further optimize patient care.
Currently deployed at several top academic medical centers, Leksell Gamma Knife Registry aims to:
- Identify global treatment patterns with Leksell Gamma Knife, and connections between treatment parameters and outcomes;
- Provide integrated longitudinal data that could help clinicians develop insights to better select patients, personalize the treatment paradigm, and improve quality; and
- Advance collaboration in clinical research.
Leksell Gamma Knife Registry encompasses a secure HIPAA-compliant data warehouse and advanced indication specific analytics. Aggregated, de-identified data can be used for studies undertaken by the global Gamma Knife community. Interactive, self-service dashboards for visual discovery and reports are included, in addition to Leksell Gamma Knife Society statistical reports.
Registry development was a joint effort between Elekta and renowned Gamma Knife centers, including the University of Pittsburgh Medical Center, and veteran Gamma Knife radiosurgery practitioners — notably, Douglas Kondziolka, M.D., professor of neurosurgery and radiation oncology at New York University School of Medicine.
“Our goal was to create new data sets, specific for Gamma Knife radiosurgery that are updated continuously and securely over the web,” Kondziolka says. “This will allow clinicians to obtain data queries in real time to benchmark their own data with those nationally or globally. Importantly, underlying these high-level views is a rich database with detailed treatment and follow-up data, which is ideally suited for research. Imagine basing a study on not 50 or 100 patients, but 10,000 or 50,000 patients on these ‘Big Data’ verified data sets. With that kind of powerful information, we may be able to really effect change in medicine.”
Elekta supports the National SRS Brain Registry, a joint effort by the American Society for Radiation Oncology (ASTRO) and AANS which seeks to define national patterns of care in radiosurgery with an eye toward improving health care outcomes, supporting informed decision making and potentially lowering the cost-of-care delivery to patients. Elekta´s Gamma Knife Registry will be utilized by participants to collect and provide data to the national effort.
For more information: www.elekta.com
September 09, 2026 
